PRESENTED AT AACR 2024
Tumor organoid and immune cells co-cultures to study myeloid cells-targeting immunotherapy
Factsheet
Explore the applications of HUB Organoids in immuno-oncology drug development
> Download now
Quick fact
Get an overview of HUB's immuno-oncology service offering
> Read now
On-demand presentation
Discover how HUB Organoids offer a shift from a “drug centric” to a “patient-centric” approach in drug development by effectively representing a patient in the lab
> Watch more
